Your browser doesn't support javascript.
loading
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis C.
Loucks, Catrina M; Lin, Jennifer J; Trueman, Jessica N; Drögemöller, Britt I; Wright, Galen E B; Chang, Wan-Chun; Li, Kathy H; Yoshida, Eric M; Ford, Jo-Ann; Lee, Samuel S; Crotty, Pam; Kim, Richard B; Al-Judaibi, Bandar; Schwarz, Ute I; Ramji, Alnoor; Farivar, Jeanette F; Tam, Edward; Walston, Lori Lee; Ross, Colin J D; Carleton, Bruce C.
Affiliation
  • Loucks CM; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Lin JJ; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Trueman JN; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Drögemöller BI; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Wright GEB; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Chang WC; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Li KH; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Yoshida EM; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Ford JA; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Lee SS; Department of Pharmacy and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Crotty P; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Kim RB; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Al-Judaibi B; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Schwarz UI; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Ramji A; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Farivar JF; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Tam E; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Walston LL; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Ross CJD; Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada.
  • Carleton BC; Division of Transplantation, University of Rochester, Rochester, New York, USA.
Liver Int ; 42(4): 796-808, 2022 04.
Article in En | MEDLINE | ID: mdl-35107877
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C, Chronic / Sofosbuvir Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C, Chronic / Sofosbuvir Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country: